Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089492
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2004-08-05
Brief Title:
A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon Enfuvirtide Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 HIV-1 Infected Patients
Sponsor:
Organization:
Hoffmann-La Roche